Altered deCode back on its feet

01.02.10 Reykjavik – Icelandic gene-hunter deCode Genetics has emerged from bankruptcy and will continue its genetics research and gene-based diagnostics as a private company, but it will abandon its efforts to develop drugs from its... more

Genomics rides a global wave

01.02.10 more

The best of European biotech

21.09.09 Two developers of therapeutic antibodies and one specialist for vaccine manu-facturing and development have been selected as this year’s finalists for the Euro­pean Biotechnica Award. The nominees for the prestigious prize, which... more

European-Russian cooperation to produce novel animal vaccines from plants

04.02.09 A new project is being launched to develop a rapid plant-based system for producing and assessing the capacity of different proteins to act as vaccines against important livestock diseases such as avian flu and blue tongue.... more

EMEA accepts Advexin

24.10.08 London – The European Medicines Agency EMEA has accepted a MAA of Introgen Therapeutics’ (Austin, USA) adenovirus p53 tumour suppressor gene therapy Advexin® to treat recurrent, refractory squamous cell carcinoma of the head and... more